FDA OKs United Therapeutics’ cancer drug

United Therapeutics, of Silver Spring, has received Food and Drug Administration approval for its cancer drug Unituxin, the company announced Tuesday. Unituxin treats the rare pediatric cancer neuroblastoma. Roger Jeffs, Ph.D., United Therapeutics' president and co-chief executive officer, said in a statement:  "We are grateful for the FDA's thorough review and collaboration on this program, ...

Leave a Reply

Your email address will not be published. Required fields are marked *